Enantiomerically pure (+)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydroisoindol-2-yl)-propionamide, and pro-drugs, metabolites, polymorphs, salts, solvates (e.g. hydrates), and clathrates thereof are discussed. Methods of treating and/or preventing various diseases and disorders, such as those ameliorated by the reduction of levels of TNF-α or the inhibition of PDE4, are also disclosed.
纯对映体的(+)-3-(3,4-二
甲氧基苯基)-3-(1-氧代-1,3-二氢异
吲哚-2-基)-丙酰胺,以及其前药、代谢物、多晶型、盐、溶剂化物(例如
水合物)和包合物均已讨论。还公开了治疗和/或预防各种疾病和障碍的方法,例如通过降低TNF-α
水平或抑制PDE4改善的疾病和障碍。